Brief: S2medical Q2 Operating Loss Narrows To SEK 5.1 Mln

S2Medical AB (publ)

25/08/2023 15:06

Aug 25 (Reuters) - S2Medical AB (publ)  S2ME.ST :
    * APRIL-JUNE NET SALES AMOUNTED TO 2.7 (0.9) MSEK
    * Q2 OPERATING COSTS HAVE DECREASED SIGNIFICANTLY COMPARED TO SAME PERIOD LAST YEAR
    * DEFAULT INTEREST ON LOAN FINANCING, WHICH WAS DUE TO BE REPAID IN DECEMBER, RESULTED IN
SIGNIFICANTLY INCREASED COSTS IN Q2, NEGATIVELY AFFECTING OVERALL RESULT
    * IS EXPECTED TO BE DEBT-FREE BY END OF JULY 2024
    * Q2 OPERATING LOSS SEK 5.1 MILLION VERSUS LOSS SEK 6.2 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr9Sm8c2 
Further company coverage:  S2ME.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))